SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU2F2
|
ENSG00000028277.16 | POU class 2 homeobox 2 |
POU3F1
|
ENSG00000185668.5 | POU class 3 homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU2F2 | hg19_v2_chr19_-_42636543_42636607 | -0.31 | 1.8e-01 | Click! |
POU3F1 | hg19_v2_chr1_-_38512450_38512474 | -0.27 | 2.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_44123734 | 7.75 |
ENST00000598676.1
|
ZNF428
|
zinc finger protein 428 |
chr19_-_44124019 | 6.37 |
ENST00000300811.3
|
ZNF428
|
zinc finger protein 428 |
chr9_-_75567962 | 4.13 |
ENST00000297785.3
ENST00000376939.1 |
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1 |
chr15_+_65337708 | 3.55 |
ENST00000334287.2
|
SLC51B
|
solute carrier family 51, beta subunit |
chr17_+_38171681 | 3.23 |
ENST00000225474.2
ENST00000331769.2 ENST00000394148.3 ENST00000577675.1 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
chr17_-_46894576 | 2.85 |
ENST00000393382.3
|
TTLL6
|
tubulin tyrosine ligase-like family, member 6 |
chr12_+_7052974 | 2.82 |
ENST00000544681.1
ENST00000537087.1 |
C12orf57
|
chromosome 12 open reading frame 57 |
chr17_-_19651668 | 2.79 |
ENST00000494157.2
ENST00000225740.6 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr16_-_30107491 | 2.71 |
ENST00000566134.1
ENST00000565110.1 ENST00000398841.1 ENST00000398838.4 |
YPEL3
|
yippee-like 3 (Drosophila) |
chr17_-_19651598 | 2.69 |
ENST00000570414.1
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr19_-_18392422 | 2.62 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
chr6_+_26183958 | 2.56 |
ENST00000356530.3
|
HIST1H2BE
|
histone cluster 1, H2be |
chr17_+_38171614 | 2.46 |
ENST00000583218.1
ENST00000394149.3 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
chr6_-_27860956 | 2.41 |
ENST00000359611.2
|
HIST1H2AM
|
histone cluster 1, H2am |
chr12_+_7053172 | 2.34 |
ENST00000229281.5
|
C12orf57
|
chromosome 12 open reading frame 57 |
chr19_-_17516449 | 2.25 |
ENST00000252593.6
|
BST2
|
bone marrow stromal cell antigen 2 |
chr17_-_19651654 | 2.18 |
ENST00000395555.3
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr17_-_36105009 | 2.13 |
ENST00000560016.1
ENST00000427275.2 ENST00000561193.1 |
HNF1B
|
HNF1 homeobox B |
chr7_-_73038822 | 2.12 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
chr7_-_73038867 | 2.10 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
chr14_+_103573853 | 2.10 |
ENST00000560304.1
|
EXOC3L4
|
exocyst complex component 3-like 4 |
chrX_+_12993202 | 2.02 |
ENST00000451311.2
ENST00000380636.1 |
TMSB4X
|
thymosin beta 4, X-linked |
chr9_-_35658007 | 2.00 |
ENST00000602361.1
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease |
chr12_+_7053228 | 1.96 |
ENST00000540506.2
|
C12orf57
|
chromosome 12 open reading frame 57 |
chr11_-_568369 | 1.92 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
chr17_+_43213004 | 1.90 |
ENST00000586346.1
ENST00000398322.3 ENST00000592162.1 ENST00000376955.4 ENST00000321854.8 |
ACBD4
|
acyl-CoA binding domain containing 4 |
chr12_-_7245125 | 1.88 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
chr1_+_149822620 | 1.86 |
ENST00000369159.2
|
HIST2H2AA4
|
histone cluster 2, H2aa4 |
chr17_-_7832753 | 1.83 |
ENST00000303790.2
|
KCNAB3
|
potassium voltage-gated channel, shaker-related subfamily, beta member 3 |
chr1_+_201979645 | 1.76 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr19_+_56111680 | 1.74 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
chr17_-_19015945 | 1.71 |
ENST00000573866.2
|
SNORD3D
|
small nucleolar RNA, C/D box 3D |
chr8_+_26435359 | 1.67 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr1_+_201979743 | 1.63 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr19_+_11466167 | 1.60 |
ENST00000591608.1
|
DKFZP761J1410
|
Lipid phosphate phosphatase-related protein type 2 |
chr6_+_37137939 | 1.60 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr19_+_39903185 | 1.59 |
ENST00000409794.3
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
chr19_-_40931891 | 1.58 |
ENST00000357949.4
|
SERTAD1
|
SERTA domain containing 1 |
chr19_+_11466062 | 1.56 |
ENST00000251473.5
ENST00000591329.1 ENST00000586380.1 |
DKFZP761J1410
|
Lipid phosphate phosphatase-related protein type 2 |
chr1_-_228645556 | 1.55 |
ENST00000366695.2
|
HIST3H2A
|
histone cluster 3, H2a |
chr17_+_19091325 | 1.53 |
ENST00000584923.1
|
SNORD3A
|
small nucleolar RNA, C/D box 3A |
chr6_+_27114861 | 1.52 |
ENST00000377459.1
|
HIST1H2AH
|
histone cluster 1, H2ah |
chr7_-_100183742 | 1.50 |
ENST00000310300.6
|
LRCH4
|
leucine-rich repeats and calponin homology (CH) domain containing 4 |
chr9_+_136325089 | 1.45 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
chr14_+_65007177 | 1.44 |
ENST00000247207.6
|
HSPA2
|
heat shock 70kDa protein 2 |
chr7_-_27153454 | 1.43 |
ENST00000522456.1
|
HOXA3
|
homeobox A3 |
chr16_+_2198604 | 1.43 |
ENST00000210187.6
|
RAB26
|
RAB26, member RAS oncogene family |
chr1_+_149858461 | 1.40 |
ENST00000331380.2
|
HIST2H2AC
|
histone cluster 2, H2ac |
chr3_-_148939835 | 1.38 |
ENST00000264613.6
|
CP
|
ceruloplasmin (ferroxidase) |
chr5_-_141030943 | 1.37 |
ENST00000522783.1
ENST00000519800.1 ENST00000435817.2 |
FCHSD1
|
FCH and double SH3 domains 1 |
chr2_-_239148599 | 1.33 |
ENST00000409182.1
ENST00000409002.3 ENST00000450098.1 ENST00000409356.1 ENST00000409160.3 ENST00000409574.1 ENST00000272937.5 |
HES6
|
hes family bHLH transcription factor 6 |
chrX_+_12993336 | 1.30 |
ENST00000380635.1
|
TMSB4X
|
thymosin beta 4, X-linked |
chr19_+_17858509 | 1.30 |
ENST00000594202.1
ENST00000252771.7 ENST00000389133.4 |
FCHO1
|
FCH domain only 1 |
chr6_-_33679452 | 1.29 |
ENST00000374231.4
ENST00000607484.1 ENST00000374214.3 |
UQCC2
|
ubiquinol-cytochrome c reductase complex assembly factor 2 |
chr15_-_41166414 | 1.26 |
ENST00000220507.4
|
RHOV
|
ras homolog family member V |
chr11_+_120107344 | 1.26 |
ENST00000260264.4
|
POU2F3
|
POU class 2 homeobox 3 |
chr6_-_26033796 | 1.20 |
ENST00000259791.2
|
HIST1H2AB
|
histone cluster 1, H2ab |
chr12_+_113344582 | 1.19 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr11_-_64085533 | 1.18 |
ENST00000544844.1
|
TRMT112
|
tRNA methyltransferase 11-2 homolog (S. cerevisiae) |
chr12_+_122064398 | 1.18 |
ENST00000330079.7
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1 |
chr6_+_27782788 | 1.17 |
ENST00000359465.4
|
HIST1H2BM
|
histone cluster 1, H2bm |
chr17_-_73127778 | 1.15 |
ENST00000578407.1
|
NT5C
|
5', 3'-nucleotidase, cytosolic |
chr19_-_893200 | 1.14 |
ENST00000269814.4
ENST00000395808.3 ENST00000312090.6 ENST00000325464.1 |
MED16
|
mediator complex subunit 16 |
chr12_-_7245018 | 1.14 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr11_+_64085560 | 1.12 |
ENST00000265462.4
ENST00000352435.4 ENST00000347941.4 |
PRDX5
|
peroxiredoxin 5 |
chr17_-_73775839 | 1.11 |
ENST00000592643.1
ENST00000591890.1 ENST00000587171.1 ENST00000254810.4 ENST00000589599.1 |
H3F3B
|
H3 histone, family 3B (H3.3B) |
chr18_-_61311485 | 1.08 |
ENST00000436264.1
ENST00000356424.6 ENST00000341074.5 |
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
chr17_+_72733350 | 1.06 |
ENST00000392613.5
ENST00000392612.3 ENST00000392610.1 |
RAB37
|
RAB37, member RAS oncogene family |
chr22_+_43011247 | 1.06 |
ENST00000602478.1
|
RNU12
|
RNA, U12 small nuclear |
chr5_+_158527630 | 1.06 |
ENST00000523301.1
|
RP11-175K6.1
|
RP11-175K6.1 |
chr16_-_88752889 | 1.01 |
ENST00000332281.5
|
SNAI3
|
snail family zinc finger 3 |
chr1_-_149814478 | 1.00 |
ENST00000369161.3
|
HIST2H2AA3
|
histone cluster 2, H2aa3 |
chr6_-_26043885 | 1.00 |
ENST00000357905.2
|
HIST1H2BB
|
histone cluster 1, H2bb |
chr19_-_50168962 | 0.99 |
ENST00000599223.1
ENST00000593922.1 ENST00000600022.1 ENST00000596765.1 ENST00000599144.1 ENST00000596822.1 ENST00000598108.1 ENST00000601373.1 ENST00000595034.1 ENST00000601291.1 |
IRF3
|
interferon regulatory factor 3 |
chr12_+_113344811 | 0.99 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr6_+_27861190 | 0.99 |
ENST00000303806.4
|
HIST1H2BO
|
histone cluster 1, H2bo |
chr22_-_29107919 | 0.98 |
ENST00000434810.1
ENST00000456369.1 |
CHEK2
|
checkpoint kinase 2 |
chr12_-_7245152 | 0.98 |
ENST00000542220.2
|
C1R
|
complement component 1, r subcomponent |
chr19_+_42788172 | 0.97 |
ENST00000160740.3
|
CIC
|
capicua transcriptional repressor |
chr1_+_228645796 | 0.96 |
ENST00000369160.2
|
HIST3H2BB
|
histone cluster 3, H2bb |
chr17_-_73127826 | 0.92 |
ENST00000582170.1
ENST00000245552.2 |
NT5C
|
5', 3'-nucleotidase, cytosolic |
chr2_+_66918558 | 0.92 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3
|
AC007392.3 |
chr17_-_7307358 | 0.91 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
chr11_-_64084959 | 0.91 |
ENST00000535750.1
ENST00000535126.1 ENST00000539854.1 ENST00000308774.2 |
TRMT112
|
tRNA methyltransferase 11-2 homolog (S. cerevisiae) |
chr19_-_50143452 | 0.90 |
ENST00000246792.3
|
RRAS
|
related RAS viral (r-ras) oncogene homolog |
chr19_+_50169081 | 0.89 |
ENST00000246784.3
|
BCL2L12
|
BCL2-like 12 (proline rich) |
chr12_+_14927270 | 0.88 |
ENST00000544848.1
|
H2AFJ
|
H2A histone family, member J |
chr7_-_17500294 | 0.88 |
ENST00000439046.1
|
AC019117.2
|
AC019117.2 |
chr5_+_2752258 | 0.87 |
ENST00000334000.3
|
C5orf38
|
chromosome 5 open reading frame 38 |
chr14_-_34420259 | 0.87 |
ENST00000250457.3
ENST00000547327.2 |
EGLN3
|
egl-9 family hypoxia-inducible factor 3 |
chr19_-_1021113 | 0.87 |
ENST00000333175.5
ENST00000356663.3 |
TMEM259
|
transmembrane protein 259 |
chr1_-_196577489 | 0.86 |
ENST00000609185.1
ENST00000451324.2 ENST00000367433.5 ENST00000367431.4 |
KCNT2
|
potassium channel, subfamily T, member 2 |
chr19_-_1132207 | 0.84 |
ENST00000438103.2
|
SBNO2
|
strawberry notch homolog 2 (Drosophila) |
chr9_+_35658262 | 0.83 |
ENST00000378407.3
ENST00000378406.1 ENST00000426546.2 ENST00000327351.2 ENST00000421582.2 |
CCDC107
|
coiled-coil domain containing 107 |
chr7_+_26438187 | 0.83 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
chr16_-_74808710 | 0.82 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
chr1_+_66797687 | 0.82 |
ENST00000371045.5
ENST00000531025.1 ENST00000526197.1 |
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr19_+_17337007 | 0.82 |
ENST00000215061.4
|
OCEL1
|
occludin/ELL domain containing 1 |
chr19_+_1269324 | 0.79 |
ENST00000589710.1
ENST00000588230.1 ENST00000413636.2 ENST00000586472.1 ENST00000589686.1 ENST00000444172.2 ENST00000587323.1 ENST00000320936.5 ENST00000587896.1 ENST00000589235.1 ENST00000591659.1 |
CIRBP
|
cold inducible RNA binding protein |
chr6_+_26273144 | 0.79 |
ENST00000377733.2
|
HIST1H2BI
|
histone cluster 1, H2bi |
chr6_-_27114577 | 0.79 |
ENST00000356950.1
ENST00000396891.4 |
HIST1H2BK
|
histone cluster 1, H2bk |
chr17_-_73127353 | 0.77 |
ENST00000580423.1
ENST00000578337.1 ENST00000582160.1 |
NT5C
|
5', 3'-nucleotidase, cytosolic |
chr9_+_35658377 | 0.77 |
ENST00000378409.3
|
CCDC107
|
coiled-coil domain containing 107 |
chr19_+_17337473 | 0.77 |
ENST00000598068.1
|
OCEL1
|
occludin/ELL domain containing 1 |
chr12_-_7245080 | 0.77 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
chr17_+_62461569 | 0.76 |
ENST00000603557.1
ENST00000605096.1 |
MILR1
|
mast cell immunoglobulin-like receptor 1 |
chr12_+_122064673 | 0.76 |
ENST00000537188.1
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1 |
chr19_-_8373173 | 0.75 |
ENST00000537716.2
ENST00000301458.5 |
CD320
|
CD320 molecule |
chr19_+_17337027 | 0.74 |
ENST00000601529.1
ENST00000600232.1 |
OCEL1
|
occludin/ELL domain containing 1 |
chr12_+_113344755 | 0.74 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr22_-_24096630 | 0.74 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr1_+_32538492 | 0.74 |
ENST00000336294.5
|
TMEM39B
|
transmembrane protein 39B |
chr12_+_132312931 | 0.73 |
ENST00000360564.1
ENST00000545671.1 ENST00000545790.1 |
MMP17
|
matrix metallopeptidase 17 (membrane-inserted) |
chr18_-_52989525 | 0.71 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr17_+_73521763 | 0.70 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr19_+_3572925 | 0.70 |
ENST00000333651.6
ENST00000417382.1 ENST00000453933.1 ENST00000262949.7 |
HMG20B
|
high mobility group 20B |
chr20_+_33292068 | 0.69 |
ENST00000374810.3
ENST00000374809.2 ENST00000451665.1 |
TP53INP2
|
tumor protein p53 inducible nuclear protein 2 |
chr19_-_45982076 | 0.69 |
ENST00000423698.2
|
ERCC1
|
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr6_-_27775694 | 0.68 |
ENST00000377401.2
|
HIST1H2BL
|
histone cluster 1, H2bl |
chr3_-_178969403 | 0.68 |
ENST00000314235.5
ENST00000392685.2 |
KCNMB3
|
potassium large conductance calcium-activated channel, subfamily M beta member 3 |
chr7_-_44122063 | 0.67 |
ENST00000335195.6
ENST00000395831.3 ENST00000414235.1 ENST00000452049.1 ENST00000242248.5 |
POLM
|
polymerase (DNA directed), mu |
chr1_+_167298281 | 0.66 |
ENST00000367862.5
|
POU2F1
|
POU class 2 homeobox 1 |
chr16_+_56691606 | 0.66 |
ENST00000334350.6
|
MT1F
|
metallothionein 1F |
chr19_-_40596767 | 0.65 |
ENST00000599972.1
ENST00000450241.2 ENST00000595687.2 |
ZNF780A
|
zinc finger protein 780A |
chr19_+_17337406 | 0.65 |
ENST00000597836.1
|
OCEL1
|
occludin/ELL domain containing 1 |
chr12_-_51611477 | 0.65 |
ENST00000389243.4
|
POU6F1
|
POU class 6 homeobox 1 |
chr19_-_50169064 | 0.65 |
ENST00000593337.1
ENST00000598808.1 ENST00000600453.1 ENST00000593818.1 ENST00000597198.1 ENST00000601809.1 ENST00000377139.3 |
IRF3
|
interferon regulatory factor 3 |
chr5_+_158527485 | 0.65 |
ENST00000517335.1
|
RP11-175K6.1
|
RP11-175K6.1 |
chr19_-_19281054 | 0.64 |
ENST00000424583.2
ENST00000410050.1 ENST00000409224.1 ENST00000409447.2 |
MEF2B
|
myocyte enhancer factor 2B |
chr9_+_92219919 | 0.64 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr3_-_129407535 | 0.63 |
ENST00000432054.2
|
TMCC1
|
transmembrane and coiled-coil domain family 1 |
chr2_-_158182105 | 0.63 |
ENST00000409925.1
|
ERMN
|
ermin, ERM-like protein |
chr12_+_123944070 | 0.62 |
ENST00000412157.2
|
SNRNP35
|
small nuclear ribonucleoprotein 35kDa (U11/U12) |
chr8_+_42396274 | 0.61 |
ENST00000438528.3
|
SMIM19
|
small integral membrane protein 19 |
chr2_-_239197201 | 0.61 |
ENST00000254658.3
|
PER2
|
period circadian clock 2 |
chr17_+_40118759 | 0.61 |
ENST00000393892.3
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase |
chr19_-_41903161 | 0.60 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
chr7_-_27183263 | 0.60 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr14_+_93389425 | 0.59 |
ENST00000216492.5
ENST00000334654.4 |
CHGA
|
chromogranin A (parathyroid secretory protein 1) |
chr12_-_11091862 | 0.58 |
ENST00000537503.1
|
TAS2R14
|
taste receptor, type 2, member 14 |
chr3_+_119316721 | 0.56 |
ENST00000488919.1
ENST00000495992.1 |
PLA1A
|
phospholipase A1 member A |
chr22_-_24096562 | 0.56 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chrX_-_80457385 | 0.56 |
ENST00000451455.1
ENST00000436386.1 ENST00000358130.2 |
HMGN5
|
high mobility group nucleosome binding domain 5 |
chr6_-_52628271 | 0.56 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
chr10_-_10504285 | 0.56 |
ENST00000602311.1
|
RP11-271F18.4
|
RP11-271F18.4 |
chr1_-_23886285 | 0.56 |
ENST00000374561.5
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
chr1_+_32666188 | 0.56 |
ENST00000421922.2
|
CCDC28B
|
coiled-coil domain containing 28B |
chr16_-_21314360 | 0.55 |
ENST00000219599.3
ENST00000576703.1 |
CRYM
|
crystallin, mu |
chr2_-_158182322 | 0.55 |
ENST00000420719.2
ENST00000409216.1 |
ERMN
|
ermin, ERM-like protein |
chr3_-_192445289 | 0.55 |
ENST00000430714.1
ENST00000418610.1 ENST00000448795.1 ENST00000445105.2 |
FGF12
|
fibroblast growth factor 12 |
chr12_-_56359802 | 0.54 |
ENST00000548803.1
ENST00000449260.2 ENST00000550447.1 ENST00000547137.1 ENST00000546543.1 ENST00000550464.1 |
PMEL
|
premelanosome protein |
chr6_-_82462425 | 0.54 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr1_+_61547894 | 0.54 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr20_+_57226841 | 0.53 |
ENST00000358029.4
ENST00000361830.3 |
STX16
|
syntaxin 16 |
chr2_-_239197238 | 0.52 |
ENST00000254657.3
|
PER2
|
period circadian clock 2 |
chrX_+_154114635 | 0.52 |
ENST00000369446.2
|
F8A1
|
coagulation factor VIII-associated 1 |
chr17_-_46682321 | 0.52 |
ENST00000225648.3
ENST00000484302.2 |
HOXB6
|
homeobox B6 |
chr19_-_40791302 | 0.52 |
ENST00000392038.2
ENST00000578123.1 |
AKT2
|
v-akt murine thymoma viral oncogene homolog 2 |
chr6_+_10585979 | 0.51 |
ENST00000265012.4
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
chr9_-_32526299 | 0.51 |
ENST00000379882.1
ENST00000379883.2 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr2_+_145780739 | 0.51 |
ENST00000597173.1
ENST00000602108.1 ENST00000420472.1 |
TEX41
|
testis expressed 41 (non-protein coding) |
chr14_-_24615523 | 0.50 |
ENST00000559056.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr1_-_149859466 | 0.50 |
ENST00000331128.3
|
HIST2H2AB
|
histone cluster 2, H2ab |
chr18_+_44526786 | 0.50 |
ENST00000245121.5
ENST00000356157.7 |
KATNAL2
|
katanin p60 subunit A-like 2 |
chr17_+_72426891 | 0.50 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr11_-_2906979 | 0.50 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr11_+_537494 | 0.50 |
ENST00000270115.7
|
LRRC56
|
leucine rich repeat containing 56 |
chr12_-_11150474 | 0.49 |
ENST00000538986.1
|
TAS2R20
|
taste receptor, type 2, member 20 |
chr2_+_174219548 | 0.48 |
ENST00000347703.3
ENST00000392567.2 ENST00000306721.3 ENST00000410101.3 ENST00000410019.3 |
CDCA7
|
cell division cycle associated 7 |
chr16_-_73082274 | 0.48 |
ENST00000268489.5
|
ZFHX3
|
zinc finger homeobox 3 |
chr6_-_89927151 | 0.48 |
ENST00000454853.2
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
chr5_-_81574160 | 0.48 |
ENST00000510210.1
ENST00000512493.1 ENST00000507980.1 ENST00000511844.1 ENST00000510019.1 |
RPS23
|
ribosomal protein S23 |
chr12_+_49297887 | 0.47 |
ENST00000266984.5
|
CCDC65
|
coiled-coil domain containing 65 |
chr4_-_71532339 | 0.47 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chrX_-_154688276 | 0.47 |
ENST00000369445.2
|
F8A3
|
coagulation factor VIII-associated 3 |
chr19_+_14444525 | 0.47 |
ENST00000588275.1
|
CTC-548K16.1
|
CTC-548K16.1 |
chr2_-_2334888 | 0.47 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
chr12_-_11214893 | 0.47 |
ENST00000533467.1
|
TAS2R46
|
taste receptor, type 2, member 46 |
chr2_+_90192768 | 0.46 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr19_+_50169216 | 0.46 |
ENST00000594157.1
ENST00000600947.1 ENST00000598306.1 |
BCL2L12
|
BCL2-like 12 (proline rich) |
chr6_+_27215471 | 0.46 |
ENST00000421826.2
|
PRSS16
|
protease, serine, 16 (thymus) |
chr20_-_39995467 | 0.45 |
ENST00000332312.3
|
EMILIN3
|
elastin microfibril interfacer 3 |
chr4_-_71532207 | 0.45 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chrM_+_5824 | 0.45 |
ENST00000361624.2
|
MT-CO1
|
mitochondrially encoded cytochrome c oxidase I |
chr2_-_219906220 | 0.44 |
ENST00000458526.1
ENST00000409865.3 ENST00000410037.1 ENST00000457968.1 ENST00000436631.1 ENST00000341552.5 ENST00000441968.1 ENST00000295729.2 |
CCDC108
|
coiled-coil domain containing 108 |
chr12_-_58212487 | 0.44 |
ENST00000549994.1
|
AVIL
|
advillin |
chr11_-_75917569 | 0.44 |
ENST00000322563.3
|
WNT11
|
wingless-type MMTV integration site family, member 11 |
chr19_-_40596828 | 0.43 |
ENST00000414720.2
ENST00000455521.1 ENST00000340963.5 ENST00000595773.1 |
ZNF780A
|
zinc finger protein 780A |
chr17_+_68100989 | 0.43 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr15_+_67841330 | 0.43 |
ENST00000354498.5
|
MAP2K5
|
mitogen-activated protein kinase kinase 5 |
chr2_+_207804278 | 0.43 |
ENST00000272852.3
|
CPO
|
carboxypeptidase O |
chr19_+_29493456 | 0.43 |
ENST00000591143.1
ENST00000592653.1 |
CTD-2081K17.2
|
CTD-2081K17.2 |
chr7_-_27219849 | 0.42 |
ENST00000396344.4
|
HOXA10
|
homeobox A10 |
chr7_+_100183927 | 0.42 |
ENST00000241071.6
ENST00000360609.2 |
FBXO24
|
F-box protein 24 |
chr5_+_140593509 | 0.42 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
chr3_+_119316689 | 0.42 |
ENST00000273371.4
|
PLA1A
|
phospholipase A1 member A |
chr1_+_203096831 | 0.41 |
ENST00000337894.4
|
ADORA1
|
adenosine A1 receptor |
chr5_+_159895275 | 0.41 |
ENST00000517927.1
|
MIR146A
|
microRNA 146a |
chr1_+_225600404 | 0.41 |
ENST00000366845.2
|
AC092811.1
|
AC092811.1 |
chr6_-_53013620 | 0.41 |
ENST00000259803.7
|
GCM1
|
glial cells missing homolog 1 (Drosophila) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 7.1 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.7 | 2.2 | GO:1901253 | negative regulation of dendritic cell cytokine production(GO:0002731) negative regulation of intracellular transport of viral material(GO:1901253) |
0.7 | 4.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.5 | 2.1 | GO:0035565 | regulation of pronephros size(GO:0035565) pronephric nephron tubule development(GO:0039020) |
0.4 | 2.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 3.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 5.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 4.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 1.0 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.3 | 2.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 3.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.8 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 3.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.6 | GO:1900738 | dense core granule biogenesis(GO:0061110) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 1.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.2 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.6 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.1 | 1.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 1.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.4 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.1 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.5 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 0.5 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 2.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 1.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 2.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 2.8 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.3 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.3 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.1 | 0.3 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 1.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.2 | GO:1905069 | allantois development(GO:1905069) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.1 | 0.2 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.1 | 8.1 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.5 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 1.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 2.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.7 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.9 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.2 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.1 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 2.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.1 | 1.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 1.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.2 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.0 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0060532 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.0 | 1.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:2000979 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.0 | 0.3 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.2 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.0 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 4.0 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 2.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 2.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.1 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.0 | 1.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.0 | 0.3 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 2.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 1.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 1.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.8 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.5 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.5 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.7 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.8 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
0.0 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.7 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 1.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.4 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.0 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.0 | 0.5 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 2.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.2 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 5.8 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 1.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 2.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 2.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 1.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 3.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 1.1 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 3.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 2.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0043025 | neuronal cell body(GO:0043025) cell body(GO:0044297) |
0.0 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 2.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 1.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 1.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 11.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.3 | 2.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.3 | 1.2 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.2 | 0.7 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.2 | 2.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 2.8 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 1.0 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 0.6 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 2.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 1.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.3 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.3 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.4 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.1 | 0.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.1 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 2.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0030109 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 6.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 5.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 2.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0010736 | serum response element binding(GO:0010736) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 1.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 2.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 1.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 7.8 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 2.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 2.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 2.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 7.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 2.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 6.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 1.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 1.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 2.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 2.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 3.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |